According to filings with the U.S. Securities and Exchange Commission, BEKHealth is raising up to $4,624,176.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Levin played a key…
According to filings with the U.S. Securities and Exchange Commission, BEKHealth is raising $7,395,353.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Jason Baumgartner played a key…
According to filings with the U.S. Securities and Exchange Commission, EvolveImmune Therapeutics is raising $26,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Stephen Bloch played a key role in…
Branford, CT – According to filings with the U.S. Securities and Exchange Commission, Enrich Therapeutics is raising $4,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dong Wang played a…
Branford, CT – According to filings with the U.S. Securities and Exchange Commission, IsoPlexis is raising $85,000,061.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sean Mackay played a key…